Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

Trial Profile

Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2017

At a glance

  • Drugs Samarium-153-SM-lexidronam (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Aug 2017 Planned End Date changed from 1 Jun 2018 to 1 Jun 2020.
    • 15 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.
    • 21 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top